期刊文献+

Film forming systems for topical and transdermal drug delivery 被引量:6

Film forming systems for topical and transdermal drug delivery
下载PDF
导出
摘要 Skin is considered as an important route of administration of drugs for both local and systemic effects. The effectiveness of topical therapy depends on the physicochemical properties of the drug and adherence of the patient to the treatment regimen as well as the system’s ability to adhere to skin during the therapy so as to promote drug penetration through the skin barrier.Conventional formulations for topical and dermatological administration of drugs have certain limitations like poor adherence to skin, poor permeability and compromised patient compliance.For the treatment of diseases of body tissues and wounds, the drug has to be maintained at the site of treatment for an effective period of time. Topical film forming systems are such developing drug delivery systems meant for topical application to the skin, which adhere to the body, forming a thin transparent film and provide delivery of the active ingredients to the body tissue. These are intended for skin application as emollient or protective and for local action or transdermal penetration of medicament for systemic action. The transparency is an appreciable feature of this polymeric system which greatly influences the patient acceptance.In the current discussion, the film forming systems are described as a promising choice for topical and transdermal drug delivery. Further the various types of film forming systems (sprays/solutions, gels and emulsions) along with their evaluation parameters have also been reviewed. Skin is considered as an important route of administration of drugs for both local and systemic effects. The effectiveness of topical therapy depends on the physicochemical properties of the drug and adherence of the patient to the treatment regimen as well as the system’s ability to adhere to skin during the therapy so as to promote drug penetration through the skin barrier.Conventional formulations for topical and dermatological administration of drugs have certain limitations like poor adherence to skin, poor permeability and compromised patient compliance.For the treatment of diseases of body tissues and wounds, the drug has to be maintained at the site of treatment for an effective period of time. Topical film forming systems are such developing drug delivery systems meant for topical application to the skin, which adhere to the body, forming a thin transparent film and provide delivery of the active ingredients to the body tissue. These are intended for skin application as emollient or protective and for local action or transdermal penetration of medicament for systemic action. The transparency is an appreciable feature of this polymeric system which greatly influences the patient acceptance.In the current discussion, the film forming systems are described as a promising choice for topical and transdermal drug delivery. Further the various types of film forming systems (sprays/solutions, gels and emulsions) along with their evaluation parameters have also been reviewed.
出处 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2017年第6期487-497,共11页 亚洲药物制剂科学(英文)
基金 Vivekanand Education Society’s College of Pharmacy, Chembur, Mumbai, for their support and encouragement
关键词 Film FORMING POLYMERS TOPICAL DRUG delivery GELLING AGENTS Film forming polymers Topical drug delivery Gelling agents
  • 相关文献

参考文献3

二级参考文献14

  • 1Genazzani AR, Gambacciani M. HRT in the third millennium [J]. Maturitas, 2001, 38: S49-S55.
  • 2O'Connell MB. Pharmacokinetic and pharmacologic variation between different estrogen products [J]. J Clin Pharmacol, 1995, 35: S18-S24.
  • 3Obach RS, Lombardo F, Waters NJ. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds [J]. Drug Metab Dispos, 2008, 36: 1385-1405.
  • 4Lievertz RW. Pharmacology and pharmacokinetics of estrogens [J]. Am J Obstet Gynecol, 1987, 156: 1289-1293.
  • 5Zheng CX, Liang WQ. Current situation of vaginal drug delivery system [J]. 中国现代应用药学, 2002, 19: 465-469.
  • 6Archer DF. Percutaneous 17 beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women [J]. Menopause, 2003, 10: 516-521.
  • 7O'Connell K, Burkman RT. The transdermal contraceptive patch: an updated review of the literature [J]. Clin Obstet Gynecol, 2007, 50:918-926.
  • 8Meshalkin YP, Artyukhov VY, Pomogaev VA. Optical properties of two types of sex hormones of the cyclopentenephenanthrene series [J]. Opt Spectrosc, 2003, 95: 377-380.
  • 9Jenquin MR, McGinity JW. Characterization of acrylic resin matrix films and mechanisms of drug-polymer interactions [J]. Int J Pharm, 1994, 101: 23-34.
  • 10Moser K, Kriwet K, Kalia YN, et al. Enhanced skin permeation of a lipophilic drug using supersaturated formulations [J]. J Control Release, 2001, 73:245-253.

共引文献11

同被引文献50

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部